Party Committee of Pharmaceutical Company Organize Experiential Training of "Casting Team" for College Students
Release time:
2020-08-14
Pharmaceutical Company organized the experiential training of "casting team" for college students
. In order to enrich the spiritual and cultural life of college students and further stimulate their work passion, sense of responsibility and team spirit, 5# August 26 , 60 college student employees from different units, departments and positions of the pharmaceutical company carried out experiential training on "taking responsibility, strengthening execution, refining morale and building teams" at Wolong Lake Outward Bound Training Base in Lanxi. All the personnel were randomly divided into four groups, and the team leader, team badge, team name and slogan were respectively established. This activity has set up training programs such as "passionate applause", "collaborative water intake", "challenge
minutes", "command from a distance" and "draw a beautiful blueprint together". Some of these programs require competition and confrontation between groups, while others require mutual cooperation and cooperation between groups, it is also interspersed with the summary and exchange of instructors, so that employees have a deeper understanding of the significance of this expansion. "collaborative water intake" project needs to stand on the ground outside the specified red line to "water intake" beyond the distance of
meters. this project tests the planning ability of team leaders and the trust among team members. In the first round, the completion time of the group with good planning was twice as fast as that of the group without planning. In the second round, after everyone learned the lessons and experiences of the first round and trusted each other more, each group made obvious progress. "Challenge
Minutes" This project requires each team owner to complete the four team cooperation projects of "Rapid Transmission", "No Forest Falling", "Everyone Jumping the Ball" and "Passionate Applause" within 5 minutes. This link tests the team's cooperation ability and tenacity. In order to complete the challenge within the limited time, the team members of each group devoted themselves wholeheartedly, made mistakes in the process of the challenge, and did not get discouraged or complain. Everyone was tenacious and finally completed the challenge successfully. The most impressive thing is the last project, called "Drawing a Beautiful Blueprint Together". Four teams competed for a day and worked together to enlarge the pattern printed with the corporate tenet of Pinnacle Pharmaceutical, "Science and Technology Brings Health", through pencils, rulers, brushes and paints, to a huge spray painting with a length of
meters and a width of about 3.75 meters. Each team made 1/4, make it and then splice it into a whole. As the huge drawing gradually took shape, every employee showed excitement and pride on his face. At the end of the drawing, everyone's emotions reached the top, and everyone couldn't help applauding enthusiastically. This experiential training not only shortens the distance between employees, enhances feelings, but also improves personal ability and team cooperation, and plays a good role in building an excellent and efficient team. (Liu Yang Hu Huihua)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page